Month |
Publication |
Title |
| September |
Business Standard |
Orchid gets ANDA's final nod from USFDA for Zaleplon Capsules |
| September |
The Economic Times |
Orchid Chem gets US nod for insomnia drug |
| September |
The Economic Times |
Orchid gets USFDA nod for injection, gets 6-mth exclusivity |
| August |
Business Standard |
Orchid Pharma settles patent row with Schering-Plough |
| August |
The Economic Times |
Orchid gets USFDA approval for migraine drug |
| July |
Business Standard |
Orchid Chem gets US FDA nod for anti-hypertensive drug |
| April |
Financial Chronicle |
Orchid takes ECB route to buy back FCCBs |
| April |
Financial Chronicle |
Orchid to bloom on new verticals |
| April |
The Hindu |
Award for Orchid’s Aurangabad unit |
| April |
DNA - Read the World |
Orchid Chem to diversify portfolio |
| February |
The Financial Express |
Orchid plans ECB to buy back FCCBs |
